ਲੇਖ
Study finds patterns in mutations of SARS-CoV‑2
Posted on 10 June, 2021 Emerging dominant strains of the coronavirus are a cause of concern as they impact the course of the pandemic, prompting scientists to track the mutation patterns of the virus closely. In this collaborative study, an analysis of the SARS-CoV‑2 global genomic database revealed the trends of point-mutations occurring in the virus.
Study finds patterns in mutations of SARS-CoV‑2Emerging dominant strains of the coronavirus are a cause of concern as they impact the course of the pandemic, prompting scientists to track the mutation patterns of the virus closely. In this collaborative study, an analysis of the SARS-CoV‑2 global genomic database revealed the trends of point-mutations occurring in the virus. |
Pangolins: An intermediate coronavirus carrier?
Posted on 24 August, 2020 Researchers have identified SARS-CoV-2 related coronaviruses in frozen pangolin samples obtained from Southern China. Pangolins and bats are the only known mammals to be infected with SARS-CoV-2 related coronaviruses, and pangolins may be an intermediate host in the spread of the virus.
Pangolins: An intermediate coronavirus carrier?Researchers have identified SARS-CoV-2 related coronaviruses in frozen pangolin samples obtained from Southern China. Pangolins and bats are the only known mammals to be infected with SARS-CoV-2 related coronaviruses, and pangolins may be an intermediate host in the spread of the virus. |
Inside a lab growing coronavirus
Posted on 12 June, 2020 In order to find a potential cure or vaccine for COVID-19, it is necessary to grow the novel coronavirus in large quantities in safe and contained laboratory settings. In the last few months, institutes around the country, including CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and National Institute of Virology (NIV), Pune, have joined the effort to grow the virus. Somdatta Karak from CCMB provides us with a first-hand peek inside one such laboratory.
Inside a lab growing coronavirusIn order to find a potential cure or vaccine for COVID-19, it is necessary to grow the novel coronavirus in large quantities in safe and contained laboratory settings. In the last few months, institutes around the country, including CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and National Institute of Virology (NIV), Pune, have joined the effort to grow the virus. Somdatta Karak from CCMB provides us with a first-hand peek inside one such laboratory. |
Controlling COVID-19 spread using instant digital contact tracing
Posted on 31 May, 2020 A new study by researchers at the University of Oxford compares various routes of SARS-CoV-2 transmission, and suggests that instantaneous digital contact tracing using a mobile app may be a more efficient way to curb its spread than manual contact tracing.
Controlling COVID-19 spread using instant digital contact tracingA new study by researchers at the University of Oxford compares various routes of SARS-CoV-2 transmission, and suggests that instantaneous digital contact tracing using a mobile app may be a more efficient way to curb its spread than manual contact tracing. |
CRISPR: a genetic surgical strike against COVID-19
Posted on 13 May, 2020 A new study explores the possibility of using CRISPR, a gene-editing tool, to inhibit the activity of the novel coronavirus
CRISPR: a genetic surgical strike against COVID-19A new study explores the possibility of using CRISPR, a gene-editing tool, to inhibit the activity of the novel coronavirus |
Will the scorching Indian summer provide respite from COVID-19?
Posted on 11 May, 2020 From the time news of the pandemic began, it was believed that summers would tone down the number of COVID-19 cases. Is this really true? A team of researchers have found that the virus that causes COVID-19, SARS-CoV-2, is indeed sensitive to higher temperatures. However, only time can tell whether this would translate to reduced transmission of the disease or deflate the virulence of the virus.
Will the scorching Indian summer provide respite from COVID-19?From the time news of the pandemic began, it was believed that summers would tone down the number of COVID-19 cases. Is this really true? A team of researchers have found that the virus that causes COVID-19, SARS-CoV-2, is indeed sensitive to higher temperatures. However, only time can tell whether this would translate to reduced transmission of the disease or deflate the virulence of the virus. |
Excerpts of the speech by Dr. K. VijayRaghavan, Principal Scientific Adviser on Arogya Setu
Posted on 06 May, 2020 K. VijayRaghavan is the principal scientific adviser to the Government of India. He is also professor emeritus and the former director of the National Centre of Biological Sciences, Bangalore. He has been part of the ICTS-TIFR Management Board since its inception. Here are excerpts from his speech about Aarogya Setu, an integrated data and decision support platform to fight the COVID-19 pandemic, on the digital platform Digital India Learning.
Excerpts of the speech by Dr. K. VijayRaghavan, Principal Scientific Adviser on Arogya SetuK. VijayRaghavan is the principal scientific adviser to the Government of India. He is also professor emeritus and the former director of the National Centre of Biological Sciences, Bangalore. He has been part of the ICTS-TIFR Management Board since its inception. Here are excerpts from his speech about Aarogya Setu, an integrated data and decision support platform to fight the COVID-19 pandemic, on the digital platform Digital India Learning. |
Modelling post-lockdown scenarios in cities
Posted on 29 April, 2020 The article describes an interactive online simulator developed by scientists from IISc and TIFR that allows the user to see how different interventions affects the number of infections, fatalities and hospitalizations over time.
Modelling post-lockdown scenarios in citiesThe article describes an interactive online simulator developed by scientists from IISc and TIFR that allows the user to see how different interventions affects the number of infections, fatalities and hospitalizations over time. |
COVID-19: Vaccine development and therapeutic strategies
Posted on 10 April, 2020 While over a million people worldwide are now confirmed to be infected with COVID-19, we do not yet have an empirical cure or a vaccine for this potentially fatal disease. In this article, Deepak Kumar Sinha, Professor at Institute of Biological Sciences, SAGE University, Indore, discusses some of the approaches being taken by researchers around the world to come up with treatment strategies and vaccines for COVID-19.
COVID-19: Vaccine development and therapeutic strategiesWhile over a million people worldwide are now confirmed to be infected with COVID-19, we do not yet have an empirical cure or a vaccine for this potentially fatal disease. In this article, Deepak Kumar Sinha, Professor at Institute of Biological Sciences, SAGE University, Indore, discusses some of the approaches being taken by researchers around the world to come up with treatment strategies and vaccines for COVID-19. |